Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Hepatic Portal System01:21

Hepatic Portal System

The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is responsible...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

[Diagnostic approach for metabolic dysfunction associated steatotic liver disease].

La Revue du praticien·2026
Same author

Efficacy and Safety of Glecaprevir/Pibrentasvir in Participants with Chronic HCV Infection and Comorbidities or Multiple Concomitant Medications: An Integrated Analysis.

Infectious diseases and therapy·2026
Same author

HCV Cure: To Bridge the Gaps in the Care Continuum.

Journal of viral hepatitis·2026
Same author

In vivo efficacy of combined human broadly neutralizing antibodies against hepatitis B virus.

Cell reports·2025
Same author

Cystic fibrosis liver disease progression in the era of elexacaftor-tezacaftor-ivacaftor.

JHEP reports : innovation in hepatology·2025
Same author

Mortality risk in migrant and non-migrant individuals with chronic hepatitis B virus infection: a French hospital-based cohort study (ANRS CO22 HEPATHER).

BMC global and public health·2025

相关实验视频

Updated: Jul 19, 2026

Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice
10:35

Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice

Published on: September 25, 2013

35.9K

[肝细胞癌 (HCC) ]

Stanislas Pol1

  • 1AP-HP. Centre Université Paris Centre, Groupe hospitalier Cochin Port Royal, Département médical universitaire de Cancérologie et spécialités médico-chirurgicales, Service des maladies du foie, Paris, France; Université Paris Cité, F-75006, Paris, France.

Medecine tropicale et sante internationale
|March 12, 2025
PubMed
概括

肝细胞癌 (HCC) 是一种主要的全球性癌症,由于病毒感染和代谢功能障碍而增加. 早期诊断和肝硬化监测对于有效治疗这种肝癌至关重要.

科学领域:

  • 肝病学 肝病学是一种肝病学.
  • 在瘤学瘤学.
  • 公共卫生 公共卫生

背景情况:

  • 肝细胞癌 (HCC) 是最常见的初级肝癌,是全球癌症的第六大原因,也是癌症相关死亡的第三大原因.
  • 在全球范围内,HCC的发病率有所不同,在肝炎病毒和真菌毒素暴露普遍的地区的发病率更高,并且经常复杂化肝硬化.
  • 增加的HCC患病率与持久性乙型肝炎 (HBV) 和C型肝炎 (HCV) 感染有关,以及与代谢功能障碍相关的非酒精性脂肪肝炎 (MASH) 的增加.

研究的目的:

  • 总结肝细胞癌 (HCC) 的流行病学,危险因素和当前治疗格局.
  • 强调对肝硬化患者的监测的重要性,使HCC的早期诊断成为可能.
  • 为了强调病毒性肝炎和代谢性疾病对HCC发病率的影响.

主要方法:

  • 文献综述和综合流行病学数据的初级肝癌,专注于HCC.
  • 分析导致HCC患病率增加的因素,包括病毒感染和代谢综合征.
  • 对HCC的诊断标准和治疗进展的概述.

主要成果:

  • 肝癌占原发性肝癌的75-85%,与肝硬化有很强的关联 (超过90%的病例).
  • 风险因素包括慢性HBV/HCV感染,滥用酒精,MASH和暴露于真菌毒素.
关键词:
肝硬化是肝硬化的一种疾病.乙型肝炎病毒的感染.肝炎C病毒/MASH 介绍 介绍肝细胞癌 肝细胞癌

更多相关视频

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
00:06

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

8.8K
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.0K

相关实验视频

Last Updated: Jul 19, 2026

Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice
10:35

Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice

Published on: September 25, 2013

35.9K
An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
00:06

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

8.8K
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.0K
  • 在治疗 (移植,手术) 和息治疗 (化疗,向疗法,免疫疗法) 方面取得了显著进展,这取决于早期诊断.
  • 结论:

    • 对肝硬化患者的定期监测对于早期检测HCC至关重要,改善治疗结果.
    • 解决病毒性肝炎和代谢相关的肝病对于减少HCC的全球负担至关重要.
    • 治疗的进步提供了更多的选择,但早期诊断仍然是有效管理HCC的关键.